Literature DB >> 30413392

Baclofen and alcohol in France.

Florian Naudet1, Alain Braillon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30413392     DOI： 10.1016/S2215-0366(18)30419-X

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  5 in total

1.  Innovation and off-label use, the French case and more.

Authors:  Alain Braillon; Joel Lexchin
Journal:  Br J Clin Pharmacol       Date:  2019-06-04       Impact factor: 4.335

Review 2.  The knowns and unknowns of treatment for alcoholic hepatitis.

Authors:  Tejasav S Sehrawat; Mengfei Liu; Vijay H Shah
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

Review 3.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546

Review 4.  Baclofen therapeutics, toxicity, and withdrawal: A narrative review.

Authors:  Jia W Romito; Emily R Turner; John A Rosener; Landon Coldiron; Ashutosh Udipi; Linsey Nohrn; Jacob Tausiani; Bryan T Romito
Journal:  SAGE Open Med       Date:  2021-06-03

5.  The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports.

Authors:  Florian Erhel; Alexandre Scanff; Florian Naudet
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-27       Impact factor: 6.892
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.